Cytosorbents Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cytosorbents Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2024.
  • Cytosorbents Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $782K, a 28% decline year-over-year.
  • Cytosorbents Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.19M, a 5.03% decline year-over-year.
  • Cytosorbents Corp annual Share-based Payment Arrangement, Expense for 2023 was $3.33M, a 2.78% decline from 2022.
  • Cytosorbents Corp annual Share-based Payment Arrangement, Expense for 2022 was $3.42M, a 14.8% decline from 2021.
  • Cytosorbents Corp annual Share-based Payment Arrangement, Expense for 2021 was $4.02M, a 14.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.19M $782K -$304K -28% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.49M $829K +$259K +45.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.23M $734K -$96K -11.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.33M $843K -$28K -3.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $3.36M $1.09M +$81K +8.06% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $3.28M $570K -$191K -25.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $3.47M $830K +$43K +5.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.42M $871K +$965K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $2.46M $1.01M +$6K +0.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.45M $761K -$797K -51.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $3.25M $787K -$771K -49.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $4.02M -$94K -$745K -114% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $4.77M $999K -$89K -8.18% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $4.86M $1.56M +$512K +48.9% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $4.34M $1.56M +$829K +114% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-02
Q4 2020 $3.51M $651K +$160K +32.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 $3.35M $1.09M +$286K +35.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $3.07M $1.05M +$901K +621% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $2.17M $729K +$501K +220% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.67M $491K -$1.08M -68.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $2.75M $802K +$528K +193% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $2.22M $145K -$1.92M -93% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $4.14M $228K -$296K -56.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $4.44M $1.57M +$110K +7.52% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 $4.33M $274K -$686K -71.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $5.01M $2.07M +$1.27M +159% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $3.75M $524K +$432K +470% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $3.31M $1.46M -$695K -32.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $4.01M $960K +$836K +674% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $3.17M $799K +$431K +117% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $2.74M $92K -$15K -14% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2.76M $2.16M +$2.07M +2439% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $684K $124K -$26K -17.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $710K $368K +$285K +343% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $425K $107K +$43K +67.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $382K $85K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $150K Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $83K Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $64K +$7K +12.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $57K -$169K -74.8% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q1 2013 $226K Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.